Hanmi Pharmaceutical Co., Ltd. 13D/13G Filings for

Hanmi Pharmaceutical Co., Ltd. 13D and 13G filings for :

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-03-20
8:54 pm
Sale
2025-03-1813DAPTOSE BIOSCIENCES INC NO
APTOF
Hanmi Pharmaceutical Co., Ltd.508,710
19.900%
-2,480,705decrease
(-82.98%)
Filing
2024-04-26
12:54 pm
Unchanged
2024-04-2413DAPTOSE BIOSCIENCES INC NO
APTOF
Hanmi Pharmaceutical Co., Ltd.2,989,415
19.020%
0
(Unchanged)
Filing
2024-02-02
6:05 pm
Purchase
2024-01-3113DAPTOSE BIOSCIENCES INC NO
APTOF
Hanmi Pharmaceutical Co., Ltd.2,989,415
22.170%
2,105,263increase
(+238.11%)
Filing
2023-09-11
6:23 pm
Purchase
2023-09-0613DAPTOSE BIOSCIENCES INC NO
APTOF
Hanmi Pharmaceutical Co., Ltd.884,152
12.070%
884,152increase
(New Position)
Filing